$9.28
-0.25 (-2.62%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-51.16%
YTD
-51.16%
Open$9.52
Previous Close$9.53
Day High$9.68
Day Low$9.26
52W High$19.95
52W Low$8.32
Volume—
Avg Volume385.1K
Market Cap1.23B
P/E Ratio4.74
EPS$10.37
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
28.7
Oversold
Analyst Ratings
Strong Buy
13 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.85B | 1.41B | 1.25B |
| Net Income | 1.01B | 696.47M | 76.97M |
| Profit Margin | 54.8% | 52.1% | 6.2% |
| EBITDA | -2,937,826,986 | -2,128,860,134 | 127.47M |
| Free Cash Flow | — | — | 81.25M |
| Rev Growth | +31.1% | +31.1% | -0.7% |
| Debt/Equity | 7.75 | 7.75 | 0.17 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.72 | +8.45% | — | 2.49B |
| DMII | Drugs Made In America Acquis | $10.17 | +0.15% | 49.8 | 647.83M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.92 | +0.18% | 42.8 | 339.80M |
| CEPF | Cantor Equity Partners-Cl A | $10.34 | -0.29% | 41.7 | 592.65M |
| BCSS | Bain Capital Gss Inv- A | $10.29 | -0.10% | 49.0 | 601.52M |